Arkolith/Insider Trading/INBX/Form 4

Kayyem Jon Faiz

DirectorInhibrx Biosciences, Inc. (INBX) · full profile →Form 4 · filed Nov 22, 2024
Net Buying
Open-Market Buys
$1.5M
Open-Market Sells
$0
Net Open-Market Flow
$1.5M
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 20, 2024Buy(P)19K$14.19$266K70K
Nov 20, 2024Buy(P)19K$14.19$266K70K
Nov 19, 2024Buy(P)35K$14.23$496K51K
Nov 19, 2024Buy(P)35K$14.23$496K51K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002007919-24-000064) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML